UNC Immunotherapy Training Grant (IM-TAG)

摘要： 这是北卡罗来纳州查佩尔山大学（UNC-CH）的一个博士后培训项目 从事肿瘤免疫治疗、肿瘤免疫学或干细胞研究的基础、转化或临床研究的研究员 细胞移植免疫学免疫治疗培训补助金（IM-TAG）由一位杰出的 导师，乔纳森Serody医学博士，谁是由芭芭拉Savoldo医学博士博士两个一流的副主任协助 和医学博士本杰明·文森特这项培训计划得到了一个全国知名的辅导小组的支持， 将肿瘤和移植免疫学转化为临床的特殊设施。另外存在 世界一流的调查人员组成了内部咨询委员会和外部咨询委员会。重点 的IM-TAG在培训项目中的代表性明显不足，导致缺乏在 这些地区 IM-TAG每年支持两名博士后研究员的培训。有11名教授和8名副教授。 具有优秀资格的教授担任导师。我们已经确定了两个特殊的助理 教授，担任共同导师。这些研究者的兴趣包括1）疫苗设计和载体 代，2）过继细胞治疗，3）免疫细胞在肿瘤微环境（TME）中的作用，4） TME的免疫基因组学评估，5）增强我们对移植物抗肿瘤生物学的理解 反应和6）管理急性和慢性移植物抗宿主病的方法。有创新 培训机制，包括1）统计设计的教学课程，2）免疫基因组学课程 由世界肿瘤免疫基因组学专家监督和数据评估，以及3）参与免疫治疗 工作组是协助开发新型免疫疗法的翻译团队， 允许学员参与IND和临床试验的开发。我们有一个全面的 培训代表性不足的少数群体的方法，包括为本科生开设暑期课程， 为他们提供免疫治疗或移植免疫学方面的实践经验。 该计划的优势包括：1）一个资金雄厚、经验丰富的导师团队 培养博士后研究员，2）具有悠久的领导合作历史的优秀领导团队 研究建议，3）以及世界一流的疫苗和移植基础设施的存在， 可以访问。这个计划结合了导师，基金会，和资源的一个国家公认的肿瘤 免疫学、癌症免疫治疗和移植免疫学项目， 加强对代表性不足的个人的垂直培训，并加强从替补到床边的发展， 接受过该项目培训的个人提供的治疗方法。

Abstract: This is a training program from the University of North Carolina at Chapel Hill (UNC-CH) to train postdoctoral fellows in basic, translational or clinical research focusing on tumor immunotherapy, tumor immunology or stem cell transplantation immunology. The UNC Immunotherapy Training Grant (IM-TAG) is led by an exceptional mentor, Jonathan Serody MD, who is assisted by two superb Associate Directors in Barbara Savoldo MD PhD and Benjamin Vincent MD. This training proposal is supported by a nationally renowned mentorship group and exceptional facilities for translation of tumor and transplantation immunology to the clinic. Additionally, there are world-class investigators that make up the Internal Advisory Committee and External Advisory Board. The focus of IM-TAG is significantly underrepresented in training programs leading to a paucity of investigators working in these areas. IM-TAG supports the training of two postdoctoral fellows yearly. There are 11 Professors, and eight Associate Professors, with outstanding qualifications who serve as mentors. We have identified two exceptional Assistant Professors, who serve as co-mentors. These investigators’ interests include 1) vaccine design and vector generation, 2) adoptive cellular therapy, 3) the role of immune cells in the tumor microenvironment (TME), 4) immunogenomic assessment of TME, 5) enhancing our understanding of the biology of the graft-versus-tumor response and 6) approaches to manage acute and chronic graft-versus-host disease. There are innovative mechanisms for training that include 1) didactic coursework in statistical design, 2) immunogenomic coursework and data evaluation overseen by world experts in tumor immunogenomics, and 3) participation in Immunotherapy Working Groups, which are translational teams that assist in the development of novel immunotherapies, allowing trainees to be involved in the development of INDs and clinical trials. We have a comprehensive approach to training underrepresented minorities, including a summer course for undergraduate students to provide them with hands-on experience in immunotherapy or transplantation immunology. Strengths of the program include 1) an extremely well-funded group of mentors with substantial experience training postdoctoral fellows, 2) an outstanding leadership group with a long history of leading collaborative research proposals, 3) and the presence of a world-class vaccine and transplantation infrastructure that trainees can access. This program combines the mentors, foundation, and resources of a nationally recognized tumor immunology, cancer immunotherapy and transplantation immunology program with novel approaches to enhance the vertical training of underrepresented individuals and enhance the bench to bedside development of therapeutics by individuals who are trained in this program.